Platelet monitoring follow-up in a pregnant patient with HELLP syndrome

Gerhardus J. A. J. M. Kuiper, Marcus D. Lance*, Valerie M. Smit-Fun, Louis L. H. Peeters, Marco A. E. Marcus

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Web of Science)

Abstract

Monitoring the course of platelet function in HELLP (haemolysis, elevated liver-enzymes and low platelets) syndrome is important for clinical decision-making. We present a primigravid woman developing HELLP syndrome at 29 weeks and 6 days. Platelet function was monitored by multiple electrode aggregometry (MEA), platelet function analyzer (PFA-100 (R) A (R)), platelet count and mean platelet volume (MPV) over an 11-day period. MPV and PFA-100 (R) A (R) seem better predictors for platelet function than platelet levels.
Original languageEnglish
Pages (from-to)160-163
JournalPlatelets
Volume22
Issue number2
DOIs
Publication statusPublished - 2011

Cite this